Dr. William C. Cho has been recognized as “Highly Cited Researchers for 2023” by Clarivate. He is a Chartered Scientist (UK), and Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science, and Hong Kong Society for Molecular Diagnostic Sciences. Dr. Cho’s research endeavors focus on cancer biomarkers, non-coding RNA, genomics, proteomics, next-generation sequencing, bioinformatics, meta-analysis, etc. His prolific contributions include over 600 peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, JAMA Oncology, Advanced Science, Nature Communications, PNAS, Molecular Cancer, Journal of Thoracic Oncology, Journal of the National Cancer Institute, Journal of Extracellular Vesicles, eClinicalMedicine, Science Advances, Theranostics, Clinical Cancer Research, Clinical Chemistry,etc.) covering cancer biomarkers, proteomics, non-coding RNA, traditional Chinese medicine, and dozens of books (including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications” and “Resistance to Anti-CD20 Antibodies and Approaches for Their Reversal”, etc.), and have received a citation count surpassing 28,000.
